Bristol Myers Squibb · 14 hours ago
Associate Director, US Cardiovascular Commercialization Learning
Bristol Myers Squibb is a leading biopharmaceutical company dedicated to transforming patients' lives through science. They are seeking an Associate Director to lead the US Cardiovascular Commercialization Learning team, responsible for creating and executing strategic learning plans and developing a high-performing training team.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Hire, build and lead a high-performing US Cardiovascular Commercialization Learning Team that is a trusted and valued partner with Sales, Marketing, Medical, Legal, Regulatory and WWCL teams
Create, communicate, and execute a unified Team Vision, Objectives and Standards of Behavior
Ensure delivery of well thought out and commercially aligned US Cardiovascular Strategic Learning Plans for all prioritized brands and launch assets ensuring they are updated routinely according to evolving business needs
Oversee the design and delivery of learning programs leveraging innovative technology focused on Sales Force onboarding, capability building, knowledge sharing, and creating a sustainable learning ecosystem
Assess and analyze the effectiveness of assigned training programs and initiatives utilizing Kirkpatrick Model
Develop and retain a high performing team of Learning Managers while building and maintaining a strong and diverse talent bench for future staffing needs
Elevate team culture fostering connectivity, empowerment, diverse and inclusive learning and behaviors, and consistent talent development unique to the individual
Effectively navigate the matrix to develop and maintain strong relationships with other functional areas to drive alignment, consistency where appropriate, best practice sharing, and flawless implementation of all training activities
Streamline and align training delivery across brands to ensure consistent quality experience for learners
Ensure comprehensive product and business acumen expertise is maintained among training team
Synthesize and share input from all key stakeholders to identify and analyze trends and/or changes which will influence training and development now and, in the future
Collaborate with other key leaders across the Enterprise to ensure learning strategies align with the Business strategies, to build on the BMS Enterprise-wide learning strategy and talent initiatives, reflects compliance requirements, elevates organizational performance, and advances the culture plan
Develop and maintain up-to-date knowledge, expertise and insight in adult learning trends and best practices
Participate and/or lead strategic initiatives across WW and USCL in conjunction with the USCL Leadership Team
Qualification
Required
Bachelor's degree or equivalent required; Master's or Doctorate degree preferred
3-7 years of experience delivering learning in biopharmaceutical industry or another highly regulated environment required
Cardiovascular experience a plus, particularly in heart arrhythmias or structural heart
Proven track record of building, inspiring and leading teams to meet or exceed objectives is essential
Successful strategy development and implementation in a complex environment
Deep knowledge in the areas of learning operations and governance, change management, and leading practices in learning & development
Proven experience with modern learning methodologies and delivery processes including digital, and capability development program design and implementation
Demonstrated strategic, forward-thinking, agile, enterprise mindset
Customer-service mindset and skilled in consulting and influencing across a complex, diverse, global, matrix organization
Demonstrated excellence in verbal and written communication skills including, ability to understand and communicate business needs and ability to effectively communicate to and with internal and external stakeholders at all levels
Demonstrated corporate maturity
Well organized and capable of managing multiple, diverse stakeholders, priorities, and programs in a dynamic environment
Ability to prioritize business needs and make timely decisions based on available data
Proficiency in Microsoft Power Point, Excel, Word and AI applications (ChatGPT/MS Co-Pilot)
Ability to travel ~20% for multiple meeting engagements (e.g., Managers Meetings, National Plan of Action Meetings, various Training Initiatives, etc.)
Benefits
Health Coverage Medical, pharmacy, dental, and vision care.
Wellbeing Support Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Eligibility Disclosure The summer hours program is for United States (U.S.) office-based employees due to the unique nature of their work.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.33BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.75B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Recent News
2026-02-06
Company data provided by crunchbase